Balance Sheets (USD $)	Oct. 31, 2014	Jul. 31, 2014
Current assets
Cash and cash equivalents	$ 1,147,636	$ 254,770
Prepaid expenses and other current assets	534,542	24,079
Total current assets	1,682,178	278,849
Other assets
Patents and patent applications (net of accumulated amortization of $5,986 at October 31, 2014 and $5,642 at July 31, 2014)	21,464	21,808
Total assets	1,703,642	300,657
Current liabilities
Accounts payable and accrued liabilities	71,750	200,604
Accrued salaries and wages	1,638,231	1,416,651
Due to related parties	350,000	350,000
Total current liabilities	2,059,981	1,967,255
Deferred revenue	3,278,344	1,411,470
Total liabilities	5,338,325	3,378,725
Stockholders' deficit
Common stock; par value $0.001; 200,000,000 shares authorized; 178,991,893 shares issued and outstanding at October 31, 2014 and 178,207,278 shares issued and outstanding at July 31, 2014	178,991	178,206
Additional paid-in capital	43,294,876	43,076,939
Accumulated deficit during the development stage	(47,108,550)	(46,333,213)
Total stockholders' deficit	(3,634,683)	(3,078,068)
Total liabilities and stockholders' deficit	$ 1,703,642	$ 300,657